A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation.
J.C. Callaway, Charles S. Grob, Dennis J. Mckenna, David E. Nichols, Alexander Shulgins, Kenneth W. Tupper
J Anal Toxicol July 1, 2006 DOI: 10.1093/jat/30.6.406 via PubMed
Summary
AI-generated from the abstractA published case report about someone ingesting 5-MeO-DMT in an ayahuasca preparation contained unclear or ambiguous details, prompting a call for greater clarity and precision in such scientific accounts. The authors argue that accurate reporting is essential for understanding risks, ensuring public safety, and supporting harm reduction in the context of psychoactive substances.
Study at a glance
| Characteristics | Scholarly critique Case report Peer reviewed |
|---|---|
| Topics | 5-MeO-DMT Ayahuasca |
| Keywords | Psychoactive substances Psychedelics Entheogens Hallucinogens Psychoactives |
| Citations | 33 |
| Key finding | A published case report on 5-MeO-DMT in ayahuasca lacked sufficient clarity, and greater precision in reporting is needed for safety and understanding. |
Abstract
A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation.